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BRIEF COMMUNICATION
EVALUATION OF ENTEROVIRUS 71 IMMUNE STATUS IN SÃO PAULO STATE, BRAZIL
Adriana LUCHS, Audrey CILLI, Denise H. RUSSO, Fernanda F. COSTA, Rita de Cássia C. CARMONA & Maria do Carmo S.T. TIMENETSKY
SUMMARY
Antibodies to Enterovirus 71 (EV71) were evaluated in São Paulo State during 1999-2005. The titer of neutralizing antibodies 
against EV71 was determined by microneutralization assay, and a titer of ≥ 1:8 was defined as indicative of protected immunity. 
Neutralizing antibodies to EV71 were observed in 12.4% (55/442) of sera samples, a low protective rate, suggesting that EV71 infection 
is uncommon in this region, but that there is a relatively high susceptibility to EV71 related diseases, which is worrying considering 
the recent Asian outbreaks. Also, a significant location-specific difference in seropositivity was observed. Neutralizing antibodies to 
EV71 were observed in 8.7% (21/241) of São Paulo metropolitan area sera samples, and 16.9% (34/201) of the sera samples from 
other municipalities. A high number of Brazilian residents live in country and coastal areas without adequate access to piped water 
or sanitation. This situation may contribute to the EV71 dissemination in these zones. The analysis of environmental samples could 
possibly make a valuable contribution to studies on the epidemiology of EV71.
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Enterovirus 71 (EV71) belongs to the enterovirus genus of the 
Picornaviridae family, and its infections are manifested most frequently 
as a mild exanthema known as hand, foot and mouth disease (HFMD)5. 
Otherwise, among the enteroviruses, (except polioviruses), EV71 
infections are the most important type because they are frequently 
complicated by neurologic diseases, including encephalitis, meningitis 
and epidemic poliomyelitis-like syndromes, that have generated interest 
and subsequent public health implications9.
EV71 has emerged as a significant pathogen with potential to cause 
large outbreaks. The last 10-13 years have seen a shift in the frequency of 
reported EV71 associated with encephalitis fatalities, in particular during 
outbreaks in Malasya in 1997 and Taiwan in 19981. Several smaller scale 
outbreaks have been also recorded in Western Australia, Korea, Japan and 
Singapore1. During 2006, there occurred multiple reports of large-scale 
HFMD outbreaks in India, Thailand, Hong Kong, Malaysia, Brunei1, and, 
more recently, in China, in 200820. However, EV71 activity is not just 
confined to South East Asia. During 1983-2005, a total of 270 cases of 
EV71 were reported in United States, and it appeared among the 15 most 
common serotypes during the 2000-2005 period11. In Brazil, prospective 
studies showed that EV71 was the cause of 6% of acute poliomyelitis-like 
disease and 5% of Guillain-Barré syndrome4,19.
The serum neutralizing antibody response is the major indicator of 
EV71 infection and protective immunity. In Brazil, few studies have 
been published on the detection of neutralizing antibodies to EV71; 
in particular there is concern about its involvement in acute flaccid 
paralysis (AFP) after poliovirus eradication, which is found concentrated 
in the city of Belém, in the Northern region of the country2,7. As limited 
information is available about the level of immunity against EV71 in São 
Paulo State, in the country´s Southeastern region - especially after the 
Asian outbreaks - serological data from 1999-2005 are presented in this 
study. Previous Ethics Committee approval was granted by the Adolfo 
Lutz Institute (Ref.12∕05). This was an anonymous unlinked study and 
informed consent was not required.
Serum samples from patients with suspected enterovirus infections 
are routinely sent to the Enteric Diseases Laboratory of the Adolfo Lutz 
Institute, the sole facility responsible for Enterovirus surveillance in São 
Paulo State, in order to conduct viral investigation. The level of immunity 
against EV71 was investigated in a total of 442 randomly selected sera 
samples, obtained from a convenient retrospective sampling. Each serum 
represents one individual, and no consecutive samples were obtained 
from the same individual in different years. 
The individuals were divided in the following age strata (in years): 
0-5 (n = 155; 35.1%), preschool and kindergarten children (the mainly 
group affected by severe EV71 infections); 6-15 (n = 103; 23.3%), 
school-aged children and those of the maximum age that carries through 
AFP monitoring; and > 15 (n = 184; 41.6%), adult individuals. In this 
work, two panels of clinical samples were used. The first panel was 
of 241 serum samples from eight different municipalities in the São 
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Paulo metropolitan area (Diadema, Guarulhos, Itapecerica da Serra, 
Mogi das Cruzes, Osasco, Santa Isabel, São Bernardo do Campo and 
São Paulo), and the second panel was composed of 201 serum samples 
from 35 distinct São Paulo State municipalities, including countryside 
and coastal areas.
The titer of neutralizing antibodies against EV71 was determined 
by microneutralization assay. Sera were diluted two-fold, from 1:8 to 
1:1024, in triplicate, and each dilution was incubated for two h at 36 °C 
with a 100 × 50% cell culture infectious dose of EV71/ BrCr strain 
(PAHO-WHO). The virus-serum mixtures were added to RD cells (human 
rhabdomyosarcoma - ATCC-CCL-136), and after a 5-day incubation at 
36 °C, the cytopathic effect was assessed by phase contrast microscopy. 
A titer of ≥ 1:8 was defined as indicative of protected immunity, and 
data were analyzed by Epi Info version 3.4.3 (CDC, Atlanta, GA, USA). 
Overall, 12.4% (55/442; 95% IC 9.0-15.0%) of tested samples 
had neutralizing antibodies to EV71, and 87.6% (387/442; 95% IC 
83.9-90.1%) were negative. A different scenario has been reported in 
Germany in two distinct studies: (i) a non-age-specific evaluation of 
antibodies in the years of 1997-2007 with a seroprevalence of 60.3%5, 
and (ii) an age-adjusted evaluation of individuals ≥ one year during 2006 
with a seroprevalence of 42.8%15. In Taiwan, a seroepidemiological 
study performed in 1997 (pre-epidemic), showed rates of about 60-70% 
in adults and children older than six years of age3; and a seropositive 
rate of 50-60% in pregnant women in results from 2006 to 2008 (post-
epidemic)13. In China, EV71 antibodies were detected in 44.2% of healthy 
children aged between 1-6 in 20058.
A significant location-specific difference in seropositivity was 
observed: 8.7% (21/241; 95% IC 5.1-12.3%) of the São Paulo 
metropolitan area samples, and 16.9% (34/201; 95% IC 11.8-22.2%) of 
the samples from other municipalities showed neutralizing antibodies 
to EV71 (p = 0.014). Enterovirus are commonly acquired by fecal-oral 
contamination, therefore numerous variables may be associated with 
Enterovirus seroprevalence including sources of drinking water, sewage 
systems (or lack thereof), socioeconomic factors, and behavior relating 
to hygiene. In fact, several Enterovirus infections and viral gastroenteritis 
outbreaks have been microbiologically linked to contaminated municipal 
water supplies6,17, including in Brazil16. 
The metropolitan region of São Paulo has relatively high coverage 
levels for water supply through house connections (98.4%) and adequate 
sanitation (81.2%), while a high number of Brazilian residents live in 
country and coastal areas without adequate access to piped water or 
sanitation10. This situation may contribute to the EV71 dissemination 
in these zones. Similar data were displayed in an age-specific study 
of seroprevalence of hepatitis A conducted in central Tunisia, where 
21.3% of school children living in the urban areas and 87.7% of those 
living in rural areas had antibodies to hepatitis A12. It is a public health 
priority to improve water quality and sanitation coverage. Moreover, 
albeit indirectly, the analysis of environmental samples could possibly 
make a valuable contribution to studies on the epidemiology of EV71. 
No correlation between age groups and seropositivity were observed. 
There was no significant difference in EV71 immunity in preschool 
children aged 0-5 years (11.0%; 17/155; 95% CI 6.1-15.9%), schooling 
children aged 6-15 years (14.6%; 15/103; 95% CI 7.3-20.8%), or adults 
> 15 years (12.5%; 23/184; 95% CI 7.3-16.7%). A similar picture has 
been reported in Taiwan and Germany. In Taiwan, during 1996-1997 
(the pre-epidemic period), in a serosurvey where ≈12% of the children 
< five years had antibodies to EV71, this seroprevalence reached ≈50% 
in children aged 5-12 years14. In Germany, during 2006, there was a 
significant increase in the EV71 seroprevalence from 12% among one to 
four years-olds to 49% among five to nine years-olds15. In another study 
conducted in Germany, the seroprevalence increased with age, but ranged 
from 36.6% in preschool children aged 0-6 years, to 67.2% and 75% in 
those aged 10-15 years and adults, respectively5. 
In Brazil, two studies among children ≤ 15 years of age were 
conducted in the city of Belém. The first study, conducted in 1998, 
showed that 59.2% of the children tested positive to EV71 antibodies, 
although the seropositivity decreased with age from 45.4% in children 
< three years to 10.9% in children aged 12-15 years7. The second study, 
carried out between 1998 and 2001, presented 57.1% of seropositivity 
to EV71, but only 20.2% for children < three years2. 
To analyze the immunity level, three neutralizing titer ranges were 
defined: 1:8-1:16 (low level), 1:32-1:128 (medium level), and 1:256-
1:1024 (high level). The analysis of the immunity level in relation to 
the age of the individuals showed that the number of sera with medium 
neutralizing antibodies levels to EV71 was highest in the 0-5 year age 
group (4.5%; 7/155), followed by the > 15 (1.6%; 3/185), and the 6-15 
(1.0%; 1/103) age groups. The low immunity level to EV71 increased 
with age from 6.4% (10/155) in children aged 0-5 years to 12.6% 
(13/103) in children aged 6-15 years, but declined to 10.8% (20/185) in 
individuals over 15 years. No high neutralizing antibodies levels to EV71 
were observed. Similar data was described in Germany, where EV71 
seropositive individuals generally showed lower neutralizing antibodies 
titers when compared to Coxsackie A 1615. This same study showed 
that the number of individuals with high levels of EV71 neutralizing 
antibodies declined with age, suggesting that the reinfection of the 
elderly is rare; otherwise, the number of individuals with high levels of 
neutralizing antibodies should increase with age15. 
The EV71 seropositivity showed a different frequency for each year: 
14.3% (3/21) in 1999; 30.0% (24/80) in 2000; 4.0% (2/50) in 2001; 
4.1% (3/73) in 2002; 11.0% (11/100) in 2003; 9.2% (10/109) in 2004; 
and 22.2% (2/9) in 2005. Unfortunately, the number of sera in each year 
was flimsy, impairing the statistical analysis. In addition, case records of 
EV71 infection are not sufficiently detailed to look for temporal trends in 
occurrence of EV71 diseases across the country, and laboratory records 
of serodiagnosed EV71 are too few to aid interpretation.
The serological data obtained in this study showed a low rate of 
protective EV71 antibodies in the population of São Paulo, suggesting 
that EV71 infection is uncommon in this region, and a relatively high 
susceptibility of the inhabitants to EV71 related diseases. In accordance 
with the serological data obtained in this study, EV71 isolations in 
Brazil were very low during the 1999-2005 period11,18, as well as in 
previous times4,19. It is worth mentioning that our results correspond 
to 442 randomly selected samples of sera, obtained from a convenient 
retrospective sampling from the Enteric Diseases Laboratory, and 
presenting different symptomatologies. Therefore, the number of sera 
in each age group and/or year may be fairly small, and the study does 
not represent the prevalence in the general population. It is possible 
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that a broader sample size would be required to confirm these findings. 
The transmission of strains between countries is made easier by 
globalization, and that would favor an EV71 infection increase in many 
countries in the near future, as there are no effective steps to prevent 
its transmission, nor good therapeutic measures to control its deadly 
complications. The only means of preventing and controlling the spread 
of EV71 during outbreaks is by public health surveillance. Currently, 
there is no vaccine available for this viral infection21. Several studies 
have shown that infants of preschool age are at the highest risk of severe 
EV71 infection13, and the transmission of this virus is lower in other age 
groups14. The highly pathogenic potential of EV71 - in addition to its 
easily transmittable nature - are the causes of a very common pediatric 
disease21. These facts together suggest that public health measures should 
focus on the population most at risk.
Even though the importance of EV71 has already been defined, more 
studies are required in order to improve the knowledge of several key 
aspects related to this virus in Brazil.
RESUMO
Avaliação da situação imunitária contra Enterovírus 71 no Estado 
de São Paulo, Brasil
Anticorpos para Enterovírus 71 (EV71) foram avaliados no Estado 
de São Paulo durante 1999-2005. O título de anticorpos neutralizantes 
contra EV71 foi determinado pelo ensaio microneutralização, e um título 
de ≥ 1:8 foi definido como indicador de imunidade protetora. Anticorpos 
neutralizantes para EV71 foram observados em 12,4% (55/442) das 
amostras de soro, uma baixa taxa de proteção, sugerindo que a infecção 
pelo EV71 é incomum nesta região e que existe alta susceptibilidade a 
doenças relacionadas ao EV71, o que é preocupante considerando os 
recentes surtos asiáticos. Ainda, foi observada diferença significativa na 
soropositividade em relação à localização, onde 8,7% (21/241) e 16,9% 
(34/201) das amostras provenientes da região metropolitana de São 
Paulo, e demais municípios, respectivamente, apresentaram anticorpos 
neutralizantes para EV71. Um grande número de brasileiros vive em 
áreas rurais e à beira-mar, sem acesso adequado à água encanada ou 
saneamento. Essa situação pode contribuir para a disseminação de 
EV71 nessas regiões. A análise de amostras ambientais poderia gerar 
contribuição valiosa para estudos sobre a epidemiologia da EV71.
AUTHORS’ CONTRIBUTIONS
AL and MCSTT conceived and designed the study; AL, AC, DHR 
and FFC performed the microneutralization assay; AL, AC and DHR 
analyzed the data; AL wrote the manuscript; RCCC conducted laboratory 
supervision. All authors contributed to the preparation and revision of 
the manuscript, read and approved the final version. AL and MCSTT are 
guarantors of the paper.
REFERENCES
 1.  Bible JM, Pantelidis P, Chan PKS, Tong CYW. Genetic evolution of enterovirus 71: 
epidemiological and pathological implications. Rev Med Virol. 2007;17:371-9. 
 2.  Castro CMO, Cruz ACR, Silva EE, Gomes MLC. Molecular and seroepidemiology 
studies of enterovirus 71 infection in the state of Pará, Brazil. Rev Inst Med Trop S 
Paulo. 2005;47:65-71.
 3.  Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49:103-12.
 4.  Da Silva EE, Winkler MT, Pallansch MA. Role of enterovirus 71 in acute flaccid 
paralysis after eradication of poliovirus in Brazil. Emerg Infect Dis. 1996;2:231-3.
 5.  Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology 
of enteroviris 71 in Germany. Arch Virol. 2009;154:1139-42.
 6.  Ehlers MM, Grabow WO, Pavlov DN. Detection of enteroviruses in untreated and 
treated drinking water supplies in South Africa. Water Res. 2005;39:2253-8.
 7.  Gomes MLC, De Castro CMO, Oliveira MJ, Da Silva EE. Neutralizing antibodies 
to enterovirus 71 in Belém, Brazil. Mem Inst Oswaldo Cruz. 2002;97:47-9.
 8.  Guo XB, Zhu SL, Wang DY. Seroepidemiology investigation of HEV71 in healthy 
children of 1-6 years old in three counties of China in 2005. Zhongguo Ji Hua Mian 
Yi. 2009;15:141-4.
 9.  Hsiung GD, Wang JR. Enterovirus infections with special reference to enterovirus 
71. J Microbiol Immunol Infect. 2000; 33:1-8.
 10.  IBGE [website]. Instituto Brasileiro de Geografia e Estatística. http://www.ibge.gov.
br/home/estatistica/populacao/trabalhoerendimento/pnad2009/pnad_sintese_2009.
pdf. Access: 20/09/2010.
 11.  Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA; Centers for Disease 
Control and Prevention. Enterovirus surveillance--United States, 1970-2005. MMWR 
Surveill Summ. 2006;55:1-20.
 12.  Letaief A, Kaabia N, Gaha R, Bousaadia A, Lazrag F, Trabelsi H, et al. Age-specific 
seroprevalence of hepatitis A among school children in central Tunisia. Am J Trop 
Med Hyg. 2005;73:40-3.
 13.  Luo ST, Chiang PS, Chao AS, Liou GY, Lin R, Lin TV, et al. Enterovirus 71 maternal 
antibodies in infants, Taiwan. Emerg Infect Dis. 2009;15:581-4. 
 14.  Ooi EE, Phoon MC, Ishak B, Chan SH. Seroepidemiology of human enterovirus 71, 
Singapore. Emerg Infect Dis. 2002;8:995-7.
 15.  Rabenau HF, Richter M, Doerr HW. Hand, foot and mouth disease: seroprevalence 
of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol. 
2010;199:45-51.
 16.  Rigotto C, Victoria M, Moresco V, Kolesnikovas CK, Corrêa AA, Souza DS, et al. 
Assessment of adenovirus, hepatitis A virus and rotavirus presence in environmental 
samples in Florianopolis, South Brazil. J Appl Microbiol. 2010;109:1979-87. 
 17.  Scarcella C, Carasi S, Cadoria F, Macchi L, Pavan A, Salamana M, et al. An outbreak 
of viral gastroenteritis linked to municipal water supply, Lombardy, Italy, June 2009. 
Euro Surveill. 2009;14(29): pii: 19274.
 18.  Silva HR, Tanajura GM, Tavares-Neto J, Gomes MLC, Linhares AC, Vasconcelos 
PFC, et al. Síndrome da meningite asséptica por enterovírus e Leptospira sp em 
crianças de Salvador, Bahia. Rev Soc Bras Med Trop. 2002;35:159-65.
 19.  Takimoto S, Waldman EA, Moreira RC, Kok F, Pinheiro FP, Saes SG, et al. Enterovirus 
71 infection and acute neurological disease among children in Brazil (1988-1990). 
Trans R Soc Trop Med Hyg. 1998;92:25-8.
 20.  Yang F, Ren L, Xiong Z, Li J, Xiao Y, Zhao R, et al. Enterovirus 71 outbreak in the 
people´s Republic of China in 2008. J Clin Microbiol. 2009;47:2351-2.
 21.  Xu J, Qian Y, Wang S, Serrano JMG, Li W, Huang Z, et al. EV71: an emerging 
infectious disease vaccine target in the Far East? Vaccine. 2010;28:3516-21. 
 Received: 14 August 2010
 Accepted: 8 October 2010
